DDInter1384 DDInter833
Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases. These enzymes are extracted from porcine pancreatic glands. The pancrelipase mixture was developed by Ortho-McNeil-Janssen Pharmaceuticals, Inc and FDA approved on April 12, 2010. For further information on the components of this mixture please visit, and.
Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.
Pancrelipase {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Iron
Iron {u} (Compound) causes {v} (Side Effect) Flatulence
Flatulence {u} (Side Effect) is caused by {v} (Compound) Glycerol phenylbutyrate
Pancrelipase may cause a moderate interaction that could exacerbate diseases when taken with Iron and Iron (Compound) causes Flatulence (Side Effect) and Flatulence (Side Effect) is caused by Glycerol phenylbutyrate (Compound)